ArticleClinical and translational radiation oncology2021

Feasibility of MR-guided ultrahypofractionated radiotherapy in 5, 2 or 1 fractions for prostate cancer.

Jonathan Mohajer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.